It is advisable for a person to discuss options with their healthcare professional
For people with diabetes, semaglutide improves glycemic control, with studies reporting an average HbA1c reduction of approximately 1.5% after six months, reflecting glucose-dependent insulin secretion and a lower risk of hypoglycemia
The incidence of adverse effects, particularly gastrointestinal complications, psychiatric disorders, and ocular problems, highlights the critical need for thorough patient assessment and continuous monitoring to ensure both the safety and effectiveness of treatment
Understanding whether these symptoms result from direct drug effects, rapid weight loss, or other factors is essential for patients and clinicians
Novo Nordisk said it made a $6.5 billion investment to increase production in the U.S
Periodic visits to a physician are required